SFX by Ex Libris Inc.

Title:	Ligand-induced transformation by a noninternalizing epidermal growth factor receptor
Source:	Science [0036-8075] Wells, A yr:1990

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Jorissen, R. "Epidermal growth factor receptor: mechanisms of activation and signalling." Experimental cell research 284.1 (2003): 31-53.
description	2.	Haluska, P. "The insulin-like growth factor system in cancer." Endocrinology and metabolism clinics of North America 41.2 (2012): 335-50.
description	3.	Di Fiore, P P P. "Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells." Cell 51.6 (1988): 1063-70.
description	4.	Chen, William S. "Functional independence of the epidermal growth factor receptor from a domain required for ligand-induced internalization and calcium regulation." Cell 59.1 (1989): 33-43.
description	5.	Starbuck, C. "Mathematical model for the effects of epidermal growth factor receptor trafficking dynamics on fibroblast proliferation responses." Biotechnology progress 8.2 (1992): 132-43.
description	6.	Velu, T. "Epidermal growth factor-dependent transformation by a human EGF receptor proto-oncogene." Science 238.4832 (1987): 1408-10.
description	7.	BONISCHNETZLER, M. "MECHANISM OF EPIDERMAL GROWTH-FACTOR RECEPTOR AUTOPHOSPHORYLATION AND HIGH-AFFINITY BINDING." Proceedings of the National Academy of Sciences of the United States of America 84.22 (1987): 7832-7836.
description	8.	Zachar, V. "Identification of a tightly regulated hypoxia-response element in the promoter of human plasminogen activator inhibitor-1." Blood 99.6 (2002): 2077-83.
description	9.	Baselga, J. "The EGF receptor family as targets for cancer therapy." Oncogene 19.56 (2001): 6550-6565.
description	10.	Olayioye, N E A. "The ErbB signaling network: receptor heterodimerization in development and cancer." The EMBO journal 19.13 (2000): 3159-3167.
description	11.	Kutikhin, Anton G. "Association of polymorphisms in TLR genes and in genes of the Toll-like receptor signaling pathway with cancer risk." Human immunology 72.11 (2011): 1095-1116.
description	12.	Shu, D. "Thermodynamically stable RNA three-way junction for constructing multifunctional nanoparticles for delivery of therapeutics." Nature nanotechnology 6.10 (2011): 658-667.
description	13.	Cavenee, W K K. "The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling." The Journal of biological chemistry 272.5 (1997): 2927-2935.
description	14.	Carboni, Joan M. "BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR." Molecular cancer therapeutics 8.12 (2009): 3341-9.
description	15.	Tanno, B. "Down-regulation of insulin-like growth factor I receptor activity by NVP-AEW541 has an antitumor effect on neuroblastoma cells in vitro and in vivo." Clinical cancer research 12.22 (2006): 6772-80.
description	16.	Zuccoli, G. "Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: case report." Nutrition & metabolism 7.1 (2010): 33-39.
description	17.	Baxter, R C C. "Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities." American journal of physiology: endocrinology and metabolism 278.6 41-6 (2000): -76.
description	18.	Morandell, S. "Quantitative proteomics and phosphoproteomics reveal novel insights into complexity and dynamics of the EGFR signaling network." Proteomics 8.21 (2008): 4383-401.
description	19.	Kraut-Cohen, J., Muller, W. J., Elson, A.;, Deepika A. "Protein-tyrosine Phosphatase {epsilon} Regulates Shc Signaling in a Kinase-specific Manner: INCREASING COHERENCE IN TYROSINE PHOSPHATASE SIGNALING." The Journal of biological chemistry 271.33 (2008): 19810-20772.
description	20.	Verbeek, BS. "Overexpression of EGFR and c-erbB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts." FEBS letters 425.1 (1998): 145-50.